Enzo Biochem Inc (ENZ)
1.06
+0.02
(+1.92%)
USD |
NYSE |
May 10, 10:02
Enzo Biochem Cash from Operations (TTM): -44.40M for Jan. 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
January 31, 2024 | -44.40M |
October 31, 2023 | -41.66M |
July 31, 2023 | -36.98M |
April 30, 2023 | -29.02M |
January 31, 2023 | -24.81M |
October 31, 2022 | -19.24M |
July 31, 2022 | -16.59M |
April 30, 2022 | -7.412M |
January 31, 2022 | -4.258M |
October 31, 2021 | -4.448M |
July 31, 2021 | 0.387M |
April 30, 2021 | -4.782M |
January 31, 2021 | -11.22M |
October 31, 2020 | -16.32M |
July 31, 2020 | -17.18M |
April 30, 2020 | -15.29M |
January 31, 2020 | 11.59M |
October 31, 2019 | 8.944M |
July 31, 2019 | 4.806M |
April 30, 2019 | 5.721M |
January 31, 2019 | -18.34M |
October 31, 2018 | -11.53M |
July 31, 2018 | -2.735M |
April 30, 2018 | 1.214M |
January 31, 2018 | 3.462M |
Date | Value |
---|---|
October 31, 2017 | 2.723M |
July 31, 2017 | -0.205M |
April 30, 2017 | 34.23M |
January 31, 2017 | 30.23M |
October 31, 2016 | 39.64M |
July 31, 2016 | 53.13M |
April 30, 2016 | 21.47M |
January 31, 2016 | 22.84M |
October 31, 2015 | 12.21M |
July 31, 2015 | -3.70M |
April 30, 2015 | -7.133M |
January 31, 2015 | -3.465M |
October 31, 2014 | -1.144M |
July 31, 2014 | -1.697M |
April 30, 2014 | -4.234M |
January 31, 2014 | -10.15M |
October 31, 2013 | -11.85M |
July 31, 2013 | -10.02M |
April 30, 2013 | -8.092M |
January 31, 2013 | -6.992M |
October 31, 2012 | -5.147M |
July 31, 2012 | -5.972M |
April 30, 2012 | -9.556M |
January 31, 2012 | -9.70M |
October 31, 2011 | -8.847M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-44.40M
Minimum
Jan 2024
11.59M
Maximum
Jan 2020
-14.10M
Average
-15.29M
Median
Apr 2020
Cash from Operations (TTM) Benchmarks
Delcath Systems Inc | -31.25M |
Star Equity Holdings Inc | 2.698M |
Exact Sciences Corp | 112.02M |
CytoSorbents Corp | -21.66M |
Progyny Inc | 188.81M |